IFFIm has delivered on its goal to frontload, disbursing US$ 2.5 billion to support vaccine purchase and delivery to 71 developing countries
In the past decade, Gavi has led the effort to vaccinate more than 500 million children, saving more than 7 million lives from 2000-2015. Without IFFIm funds, this would not have been possible.
Since IFFIm’s inception in 2006 through December 2016, IFFIm funding has allowed Gavi to increase its expenditure on health programmes significantly, providing approximately one third of Gavi’s funding need over this period.
In total, US$ 2.5 billion has already been disbursed to support vaccine purchase and delivery to 71 developing countries.
In addition, IFFIm has been instrumental in helping Gavi fund breakthrough vaccines quickly and securely.
For instance, IFFIm financed more than 90% of Gavi's promised payment to UNICEF to secure initial doses of pentavalent, a single shot of which immunises against five infectious diseases: diphtheria, tetanus, pertussis, haemophilus influenzae type B (Hib) and hepatitis B.
Gavi could not have made that promise, including upfront cash payments, without its ability to rely on long-term, stable funding from IFFIm.